FDA
approval
· 2020-02-05
FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for LITHIUM CARBONATE ER from Glenmark Pharmaceuticals Inc., USA, related to the generic lithium carbonate extended-rele…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)